TrialBMC infectious diseases2022

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.

Kristin Baltrusaitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.